🔍 New Analysis from Lucid Health Consulting & Vista Health
How do health technology assessment (HTA) processes differ between Singapore and Australia and what are the strategic implications for those working across both markets?
In this piece, together with our Asia-Pacific partner, Vista Health, we unpack the core principles, key differences, and regulatory considerations that matter most to stakeholders navigating the HTA landscape.
Access the full analysis and explore more expert insights, on our Publications website page HERE
Have questions or want to discuss the findings? Send us an email or reach out to our team of market access, health economics, pricing & reimbursement and regulatory affairs experts anytime.
EMAIL: info@lucidhealthcon.com
For more insights and updates, follow us on LinkedIn
Recent Comments